Use of riluzole prodrugs to treat ataxias
US12102618B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2023 |
| Grant date | Oct 1, 2024 |
| Priority date | — |
| Expiry date | Jul 17, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D277/82
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods of treating ataxia by administering to a patient in need thereof a riluzole prodrug such as troriluzole. Pharmaceutical compositions and kits including the riluzole prodrugs are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.